Cargando…

Targeting mutant p53 in cancer: the latest insights

This commentary wishes to highlight the latest discoveries in the mutant p53 field that have been discussed in the 8th p53 Mutant Workshop 2019, held in Lyon. TP53 mutant (mutp53) proteins are involved in the pathogenesis of most human cancers. Mutp53 proteins not only lose wild-typ53 function but,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di Agostino, Silvia, Fontemaggi, Giulia, Strano, Sabrina, Blandino, Giovanni, D’Orazi, Gabriella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612074/ https://www.ncbi.nlm.nih.gov/pubmed/31277687 http://dx.doi.org/10.1186/s13046-019-1302-0

Ejemplares similares

Oncogenomic Approaches in Exploring Gain of Function of Mutant p53
por: Donzelli, Sara, et al.
Publicado: (2008)

Gain of function mutant p53 proteins cooperate with E2F4 to transcriptionally downregulate RAD17 and BRCA1 gene expression
por: Valenti, Fabio, et al.
Publicado: (2015)

Gender, mutant p53 and PML: A growing “affaire” in tumor suppression and oncogenesis
por: Di Agostino, Silvia, et al.
Publicado: (2013)

Oncogenic Intra-p53 Family Member Interactions in Human Cancers
por: Ferraiuolo, Maria, et al.
Publicado: (2016)

microRNAs: short non-coding bullets of gain of function mutant p53 proteins
por: Donzelli, Sara, et al.
Publicado: (2014)

Mutant p53 and Cellular Stress Pathways: A Criminal Alliance That Promotes Cancer Progression
por: D’Orazi, Gabriella, et al.
Publicado: (2019)

Reactivation of mutant p53 by capsaicin, the major constituent of peppers
por: Garufi, Alessia, et al.
Publicado: (2016)

Zn(II)-curc targets p53 in thyroid cancer cells
por: GARUFI, ALESSIA, et al.
Publicado: (2015)

Recent Advances in p53
por: D’Orazi, Gabriella
Publicado: (2021)

Mutant p53 Protein and the Hippo Transducers YAP and TAZ: A Critical Oncogenic Node in Human Cancers
por: Ferraiuolo, Maria, et al.
Publicado: (2017)

New therapeutic strategies to treat human cancers expressing mutant p53 proteins
por: Blandino, Giovanni, et al.
Publicado: (2018)

p53 Function and Dysfunction in Human Health and Diseases
por: D’Orazi, Gabriella
Publicado: (2023)

Long Non-coding MIR205HG Depletes Hsa-miR-590-3p Leading to Unrestrained Proliferation in Head and Neck Squamous Cell Carcinoma
por: Di Agostino, Silvia, et al.
Publicado: (2018)

p53 reactivation: The link to zinc
por: D’Orazi, Gabriella, et al.
Publicado: (2012)

Degradation of mutant p53H175 protein by Zn(II) through autophagy
por: Garufi, A, et al.
Publicado: (2014)

ID4: a new player in the cancer arena
por: Dell'Orso, Stefania, et al.
Publicado: (2010)

Interplay between Endoplasmic Reticulum (ER) Stress and Autophagy Induces Mutant p53H273 Degradation
por: Garufi, Alessia, et al.
Publicado: (2020)

The beneficial effect of Zinc(II) on low-dose chemotherapeutic sensitivity involves p53 activation in wild-type p53-carrying colorectal cancer cells
por: Garufi, Alessia, et al.
Publicado: (2015)

Targeting hypoxia in tumor: a new promising therapeutic strategy
por: Bosco, Maria Carla, et al.
Publicado: (2020)

High glucose dephosphorylates serine 46 and inhibits p53 apoptotic activity
por: Garufi, Alessia, et al.
Publicado: (2014)

A fluorescent curcumin-based Zn(II)-complex reactivates mutant (R175H and R273H) p53 in cancer cells
por: Garufi, Alessia, et al.
Publicado: (2013)

The Impact of NRF2 Inhibition on Drug-Induced Colon Cancer Cell Death and p53 Activity: A Pilot Study
por: Garufi, Alessia, et al.
Publicado: (2022)

Gentian violet induces wtp53 transactivation in cancer cells
por: GARUFI, ALESSIA, et al.
Publicado: (2014)

Nobel committee honors tumor immunologists
por: Rotte, Anand, et al.
Publicado: (2018)

HIF-1α antagonizes p53-mediated apoptosis by triggering HIPK2 degradation
por: Nardinocchi, Lavinia, et al.
Publicado: (2011)

SLC25A1, or CIC, is a novel transcriptional target of mutant p53 and a negative tumor prognostic marker
por: Kolukula, Vamsi K., et al.
Publicado: (2014)

Hippo and rassf1a Pathways: A Growing Affair
por: Fausti, Francesca, et al.
Publicado: (2012)

PML Surfs into HIPPO Tumor Suppressor Pathway
por: Strano, Sabrina, et al.
Publicado: (2013)

Unfolded p53 in the pathogenesis of Alzheimer's disease: is HIPK2 the link?
por: Stanga, Serena, et al.
Publicado: (2010)

Targeting Hypoxia in Cancer Cells by Restoring Homeodomain Interacting Protein-Kinase 2 and p53 Activity and Suppressing HIF-1α
por: Nardinocchi, Lavinia, et al.
Publicado: (2009)

The miR-205-5p/BRCA1/RAD17 Axis Promotes Genomic Instability in Head and Neck Squamous Cell Carcinomas
por: Valenti, Fabio, et al.
Publicado: (2019)

Zinc supplementation is required for the cytotoxic and immunogenic effects of chemotherapy in chemoresistant p53-functionally deficient cells
por: Cirone, Mara, et al.
Publicado: (2013)

HIPK2 modulates p53 activity towards pro-apoptotic transcription
por: Puca, Rosa, et al.
Publicado: (2009)

p53-Dependent PUMA to DRAM antagonistic interplay as a key molecular switch in cell-fate decision in normal/high glucose conditions
por: Garufi, Alessia, et al.
Publicado: (2017)

The Impact of Mutant p53 in the Non-Coding RNA World
por: Di Agostino, Silvia
Publicado: (2020)

The oncogenic role of circPVT1 in head and neck squamous cell carcinoma is mediated through the mutant p53/YAP/TEAD transcription-competent complex
por: Verduci, Lorena, et al.
Publicado: (2017)

Editorial: Human Tumor-Derived p53 Mutants: A Growing Family of Oncoproteins
por: Haupt, Ygal, et al.
Publicado: (2016)

Circular RNAs in Embryogenesis and Cell Differentiation With a Focus on Cancer Development
por: Di Agostino, Silvia, et al.
Publicado: (2020)

A ruthenium(II)-curcumin compound modulates NRF2 expression balancing the cancer cell death/survival outcome according to p53 status
por: Garufi, Alessia, et al.
Publicado: (2020)

Structural and Drug Targeting Insights on Mutant p53
por: Gomes, Ana Sara, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6d5puqtc0i8v7m27av4lsh35tr